Skip to Main Content

Paper Details

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam.
Epilepsia
11
2022
Author NameAffiliation
Roland KrauseUniversity of Luxembourg
Chantal DepondtUniversite Libre de Bruxelles
Josemir W Sander
Josemir W SanderUCL Queen Square Institute of Neurology
Josemir W Sander
Kari StefanssonInc.
Kari StefanssonUniversity of Iceland
Kari StefanssonInc.
Kari StefanssonUniversity of Iceland
Hreinn StefanssonUniversity of Iceland
Colin P DohertyFutureNeuro Research Centre
Colin P DohertyBeaumont Hospital
Erin L HeinzenSchool of Pharmacy, University of North Carolina at Chapel Hill
Ingrid E SchefferRoyal Children's Hospital, University of Melbourne
Ingrid E SchefferEpilepsy Research Centre, University of Melbourne
Ingrid E SchefferFlorey Institute and Murdoch Children's Research Institute
David B GoldsteinInstitute for Genomic Medicine, Columbia University Irving Medical Center
David B GoldsteinInstitute for Genomic Medicine, Columbia University Irving Medical Center
Terence J O'BrienMonash University
Sanjay M SisodiyaUCL Queen Square Institute of Neurology
Sanjay M Sisodiya
Norman DelantyFutureNeuro Research Centre
Norman DelantyDepartment of Pharmacy and Biomolecular Science
Norman DelantyBeaumont Hospital
Gianpiero L CavalleriFutureNeuro Research Centre
Gianpiero L CavalleriDepartment of Pharmacy and Biomolecular Science
  • 1 - 26

Datasets

Release 1.2